AMNIGRAFT

Monday, 02 October 2017 05:42
Rate this item
(0 votes)

AMNIGRAFT Wound Allograft is indicated for use as a wound covering for dermal ulcers and defects. Amnigraft reduces scar tissue
formation, modulates inflammation in the surgical site, enhances healing, and acts as a barrier.
Human amniotic membrane comprises the innermost layer of the placenta and lines the amniotic cavity. Other forms of the same type of placental tissue have been used for 100 years; this type of tissue is becoming a standard wound treatment for chronic wounds. Amnigraft is rich with the basic components necessary for tissue repair and wound healing. They contain collagen substrates, growth factors, amino acids, carbohydrates, and cytokines, which are known to facilitate migration and proliferation cells to the site of injury and help construct a natural scaffold on which new tissue growth can occur. Amnigraft is processed through the process that combines cleaning, dehydration and sterilization, and it may be stored at ambient conditions for up to 3 years. The proprietary protects the delicate scaffold during processing, leaving an intact collagen matrix. The result is a durable graft with natural barrier properties to optimize surgical performance and ease of use.

plagrafDes

Indication 

  1.  Bedsore
  2.  Diabetic foot ulcer
  3.  Buerger disease and lower limb ischemia
  4.  Trauma
  5.  Scars and wounds from surgery
  6.  Burns 

 

Benefit 

1. Biocompatibility
2. No risk of rejection
3. Reduce wound pain
4. Anti-microbial properties
5. Reducing the likelihood of tumor regrowth 
6. Observing the healing process (transparency)
7. Reduction of inflammation
8. Biodegradable (Non tissue adhesion)
9. Can be used in all parts of the body
10. Lack of local and systemic toxicity
11. Induce and accelerate cell migration
12. Appropriate for exposed wounds
13. Prevention of keloid and scar tissue formation

 

Size

 

Read 1343 times
More in this category: « SORIEF
info@nojandaroo.com

NOJANDAROO.COM

Nojan Daroo Sandos

Nojan Daroo Sandos Co., Produces High-Technology Products in the Special Treatment of Acute and Chronic Wounds and Also Exclusive Representative of Biogena Austria, France Process for PRF, Swiss SunStar Companies in Iran.

: No.52, 10. Banafsheh St. ,Otrish Sq, shahrak golestan, Tehran-Iran
: (+9821)47380-9
Contact us
  Mail is not sent.   Your email has been sent.